Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Gbs Inc. (GBS)  
$0.60 0.00 (0.00%) as of 4:30 Thu 2/9


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 11,880,000
Market Cap: 7.13(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6 - $0.6
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   GBS is a biosensor diagnostic technology company. Co.'s products are: Biosensor Platform Technology, which the Saliva Glucose Biosensor (SGB) is based is a modified Organic Thin Film Transistor; Saliva Glucose Test, which consists of the SGB, which is a single use disposable saliva biosensor, and software app on a smart device or a dedicated reader that interfaces the SGB with its digital information system; and SGB, which has the sensitivity of the glucose biosensor that enables it to detect glucose in saliva at concentrations and exhibits linear glucose sensing characteristics at these concentrations, sensing glucose at levels 100 times lower than in blood.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 121,817 121,967 142,937
Total Buy Value $0 $0 $285 $13,300
Total People Bought 0 2 3 3
Total Buy Transactions 0 2 4 6
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 10
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Parmakellis Tom Director   –       •      –    2021-06-21 4 B $4.44 $4,440 D/D 1,000 1,000 2.31 -45%     
   Sakiris Spiro Kevin Chief Financial Officer   •       –      –    2021-05-19 4 B $3.07 $30,660 D/D 10,000 16,258 2.74 -22%     
   Gavrilenko Victoria Director   –       •      –    2021-03-02 4 B $8.09 $296 D/D 37 37 2.31 -57%     
   Towers Christopher Director   –       •      –    2021-02-24 4 B $6.84 $5,472 D/D 800 800 2.39 -51%     
   Life Science Biosensor Diagnostics Pty Ltd 10% Owner   –       –       •   2021-01-18 4 OE $0.00 $0 D/D 117,647 5,786,694     -
   Sakiris Spiro Kevin Chief Financial Officer   •       –      –    2021-01-04 4 OE $0.00 $0 D/D 1,479 6,258     -
   Life Science Biosensor Diagnostics Pty Ltd 10% Owner   –       –       •   2020-12-22 3 IO $0.00 $0 D/D 0 5,747,647     -
   Simeonidis Harry CEO, PresidentOfficer   •       •      –    2020-12-22 3 IO $0.00 $0 D/D 0 600     -
   Kempler Leonard Victor Director   –       •      –    2020-12-22 3 IO $0.00 $0 D/D 0 2,450     -
   Sakiris Spiro Kevin Chief Financial OfficerOfficer   •       –      –    2020-12-22 3 IO $0.00 $0 D/D 0 1,779     -

  10 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed